Biodesix announces first quarter 2025 results and highlights

Total q1 2025 revenue of $18.0 million, an increase of 21% over q1 2024; gross margins of 79.4% for q1 2025 ; q1 2025 net loss improved by 18% compared to q1 2024; updated 2025 revenue guidance to a range of $80-85 million; conference call and webcast today at 4:30 p.m. et louisville, colo.

BDSX Ratings Summary

BDSX Quant Ranking